A Novel Yeast-Based Platform for Small Molecule Target Deconvolution Reveals Previously Unknown Binding Partners for the Approved Drugs Erlotinib, Atorvastatin, and Sulfasalazine

Thumbnail

Event details

Date 17.12.2010
Hour 17:15
Speaker Monsieur Christopher Chidley
Location
Category Thesis defenses
Directeur de thèse: prof. Kai Johnsson, Chimie et génie chimique

Practical information

  • General public
  • Free

Event broadcasted in

Share